ONLINE DATABASE SEARCH - OI-LS-356-MEMO
1. 58871 OI-LS-356; PUBMED-OI-9/5/2006
Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives
Costa, MS, Boechat, N, Rangel, EA, da, Silva FD, de Souza, AM, Rodrigues, CR, Castro, HC, Junior, IN, Lourenco, MC, Wardell, SM, and Ferreira, VF
Bioorg Med Chem 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16949290&dopt=abstract
2. 58872 OI-LS-356; EMBASE-OI-9/5/2006
The history of tuberculosis
Daniel, Thomas M
Respiratory Medicine 2006. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WWS-4KSVFY9-1/2/2e28aab732dfb775641606b64c8a0e9f
3. 58873 OI-LS-356; PUBMED-OI-9/5/2006
Comparison of susceptibility and transcription profile of the new antifungal hassallidin A with caspofungin
Neuhof, T, Seibold, M, Thewes, S, Laue, M, Han, CO, Hube, B, and von, Dohren H
Biochem Biophys Res Commun 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16949033&dopt=abstract
4. 58874 OI-LS-356; PUBMED-OI-9/5/2006
In vitro anti-mycobacterial activities of various 2'-deoxyuridine, 2'-arabinouridine and 2'-arabinofluoro-2'-deoxyuridine analogues: synthesis and biological studies
Srivastav, NC, Manning, T, Kunimoto, DY, and Kumar, R
Med Chem 2006. 2(3): 287-93
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16948475&dopt=abstract
5. 58875 OI-LS-356; EMBASE-OI-9/5/2006
Synthesis, antimycobacterial and antitumor activities of new (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl N,N-disubstituted dithiocarbamate/O-alkyldithiocarbonate derivatives
Guzel, Ozlen and Salman, Aydin
Bioorganic & Medicinal Chemistry 2006. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF8-4KPP44T-1/2/ce26b71bbfbfeee900b9cb16f8cff1ac
6. 58876 OI-LS-356; PUBMED-OI-9/5/2006
Antiviral Targets of a Chromene Derivative from Sargassum micracanthum in the Replication of Human Cytomegalovirus
Hayashi, K, Mori, J, Saito, H, and Hayashi, T
Biol Pharm Bull 2006. 29(9): 1843-7
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16946496&dopt=abstract
7. 58877 OI-LS-356; PUBMED-OI-9/5/2006
Identification of a diacylglycerol acyltransferase gene involved in accumulation of triacylglycerol in Mycobacterium tuberculosis under stress
Sirakova, TD, Dubey, VS, Deb, C, Daniel, J, Korotkova, TA, Abomoelak, B, and Kolattukudy, PE
Microbiology 2006. 152(Pt 9): 2717-25
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16946266&dopt=abstract
8. 58878 OI-LS-356; PUBMED-OI-9/5/2006
Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro
Koev, G, Dekhtyar, T, Han, L, Yan, P, Ng, TI, Lin, CT, Mo, H, and Molla, A
Antiviral Res 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16945431&dopt=abstract
9. 58879 OI-LS-356; PUBMED-OI-9/5/2006
Synthesis of pyrrolo[2,3-d]pyrimidine nucleoside derivatives as potential anti-HCV agents
Varaprasad, CV, Ramasamy, KS, Girardet, JL, Gunic, E, Lai, V, Zhong, W, An, H, and Hong, Z
Bioorg Chem 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16945403&dopt=abstract
10. 58880 OI-LS-356; PUBMED-OI-9/5/2006
Interference of Mycobacterium tuberculosis cell division by Rv2719c, a cell wall hydrolase
Chauhan, A, Lofton, H, Maloney, E, Moore, J, Fol, M, Madiraju, MV, and Rajagopalan, M
Mol Microbiol 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16942606&dopt=abstract
11. 58881 OI-LS-356; EMBASE-OI-9/5/2006
Functional and phenotypic changes in monocytes from patients with tuberculosis are reversed with treatment
Sanchez, Maria D, Garcia, Yoenis, Montes, Carlos, Paris, Sara C, Rojas, Mauricio, Barrera, Luis F, Arias, Mauricio A, and Garcia, Luis F
Microbes and Infection 2006. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6VPN-4KD584D-2/2/a975028fb711d01fc4fc54b57653a695
12. 58882 OI-LS-356; PUBMED-OI-9/5/2006
2,6-hexadecadiynoic acid and 2,6-nonadecadiynoic acid: novel synthesized acetylenic fatty acids as potent antifungal agents
Carballeira, NM, Sanabria, D, Cruz, C, Parang, K, Wan, B, and Franzblau, S
Lipids 2006. 41 (5): 507-11
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16933795&dopt=abstract
13. 58883 OI-LS-356; EMBASE-OI-9/5/2006
A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease
Kobashi, Yoshihiro, Matsushima, Toshiharu, and Oka, Mikio
Respiratory Medicine 2006. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WWS-4K42BN9-1/2/34e245a344204a429d09717f731cb62b
14. 58884 OI-LS-356; PUBMED-OI-9/5/2006
A Mycothiol Synthase Mutant of Mycobacterium tuberculosis Has an Altered Thiol-Disulfide Content and Limited Tolerance to Stress
Buchmeier, NA, Newton, GL, and Fahey, RC
J Bacteriol 2006. 188(17): 6245-52
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16923891&dopt=abstract
15. 58885 OI-LS-356; PUBMED-OI-9/5/2006
Synthesis and Biological Evaluation of Bicyclic Nucleosides as Inhibitors of M. tuberculosis Thymidylate Kinase
Van Daele, I, Munier-Lehmann, H, Hendrickx, PM, Marchal, G, Chavarot, P, Froeyen, M, Qing, L, Martins, JC, and Van Calenbergh, S
ChemMedChem 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16921580&dopt=abstract
16. 58886 OI-LS-356; PUBMED-OI-9/5/2006
Use of a codon alteration strategy in a novel approach to cloning the Mycobacterium tuberculosis diaminopimelic acid epimerase
Usha, V, Dover, LG, Roper, DL, Lloyd, AJ, and Besra, GS
FEMS Microbiol Lett 2006. 262(1): 39-47
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16907737&dopt=abstract
17. 58887 OI-LS-356; EMBASE-OI-9/5/2006
New drug candidates and therapeutic targets for tuberculosis therapy
Zhang, Ying, Post-Martens, Katrin, and Denkin, Steven
Drug Discovery Today 2006. 11(1-2): 21-27
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T64-4J853YK-4/2/2d71e2eb6a692bf973e2fcb53713a1cd
18. 58888 OI-LS-356; EMBASE-OI-9/5/2006
Origin and Development of RUTI, a New Therapeutic Vaccine Against Mycobacterium tuberculosis Infection
Cardona, PJ and Amat, I
Archivos de Bronconeumologia 2006. 42(1): 25-32
HYPERLINK:
http://www.sciencedirect.com/science/article/B8CWC-4KR39BH-6/2/03a15d57785a4ec6e28b748d8d0dde00
19. 58889 OI-LS-356; EMBASE-OI-9/5/2006
Hydrazones of 2-aryl-quinoline-4-carboxylic acid hydrazides: Synthesis and preliminary evaluation as antimicrobial agents
Metwally, Kamel A, Abdel-Aziz, Lobna M, Lashine, El-Sayed M, Husseiny, Mohamed I, and Badawy, Rania H
Bioorganic & Medicinal Chemistry 2006. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF8-4KST3FD-4/2/389b17dadb639016764cfcbc6340032e
20. 58890 OI-LS-356; WOS-OI-8/27/2006
Antimicrobial activities of cinnamyl rifamycin derivatives, T-9 and T-11, against Mycobacterium tuberculosis and Mycobacterium avium complex (MAC) with special reference to the activities against intracellular MAC
Sato, K, Shimizu, T, Dimova, V, and Tomioka, H
MICROBIOLOGY AND IMMUNOLOGY 2006. 50(8): 621-623, 3
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239522400007
21. 58891 OI-LS-356; WOS-OI-8/27/2006
Relationships between hepatitis C virus replication and CXCL-8 production in vitro
Koo, BCA, McPoland, P, Wagoner, JP, Kane, OJ, Lohmann, V, and Polyak, SJ
JOURNAL OF VIROLOGY 2006. 80(16): 7885-7893, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239557700010
22. 58892 OI-LS-356; EMBASE-OI-9/5/2006
Biologically active polymers: VII. Synthesis and antimicrobial activity of some crosslinked copolymers with quaternary ammonium and phosphonium groups
Kenawy, El-Refaie, Abdel-Hay, FImam, El-Magd, Ahmed Abou, and Mahmoud, Yehia
Reactive and Functional Polymers 2006. 66(4): 419-429
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TY0-4HKCYXH-1/2/918bcb61e7a3a51882fe3464b77e69b0
23. 58893 OI-LS-356; EMBASE-OI-9/5/2006
3-Farnesyl-2-hydroxybenzoic acid is a new anti-Helicobacter pylori compound from Piper multiplinervium
Ruegg, T, Calderon, AI, Queiroz, EF, Solis, PN, Marston, A, Rivas, F, Ortega-Barria, E, Hostettmann, K, and Gupta, MP
Journal of Ethnopharmacology 2006. 103(3): 461-467
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T8D-4HG6FVG-1/2/05c384116fb493161785d5477e4c7912
24. 58894 OI-LS-356; WOS-OI-8/27/2006
Debio-025 is a promising new drug for the treatment of chronic hepatitis C
Inoue, K, Watanabe, T, Yoshiba, M, Dumont, JM, Scalfaro, P, and Kohara, M
JOURNAL OF HEPATOLOGY 2006. 44: S153-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237328100406
25. 58895 OI-LS-356; WOS-OI-8/27/2006
Subgenomic hepatitis c replicon deriving from a clinical isolate with virologic non-response to IFN-based therapy and IFN resistance in vitro
Schonberger, B, Appel, N, Lohmann, V, Goebel, R, Bartenschlager, R, Zeuzem, S, and Sarrazin, C
JOURNAL OF HEPATOLOGY 2006. 44: S157-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237328100417
26. 58896 OI-LS-356; EMBASE-OI-9/5/2006
Antiviral drugs for cytomegalovirus diseases: Special Issue To Honour Professor Erik De Clercq
Biron, Karen K
Antiviral Research 2006. 71(2-3): 154-163
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4K18TKC-2/2/ce0b69aeadb891e3e0ca293086c8a5d7
27. 58897 OI-LS-356; WOS-OI-8/27/2006
Changing patterns in the risk for cytomegalovirus infection and disease and treatment-related outcomes in the era of preemptive antiviral therapy
Boeckh, M, Kirby, K, Norasetthada, L, Sandmaier, B, Maloney, D, Maris, M, Storb, R, and Corey, L
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 2006. 10: S31-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239428800056
28. 58898 OI-LS-356; WOS-OI-8/27/2006
Synthesis of N-3(4-(4-chlorophenyl thiazole-2-yl)-(2-(amino)methyl)-quinzoline-4(3H)-one and their derivatives for antitubercular
Pattan, SR, Reddy, VVK, Manvi, FV, Desai, BG, and Bhat, AR
INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY 2006. 45 (7): 1778-1781, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239475200020
29. 58899 OI-LS-356; WOS-OI-8/27/2006
Synthesis of 2 '-C-methylcytidine and 2 '-C-methyluridine derivatives modified in the 3 '-position as potential antiviral agents
Pierra, C, Amador, A, Badaroux, E, Storer, R, and Gosselin, G
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS 2006. 71(7): 991-1010, 20
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239593900006
30. 58900 OI-LS-356; WOS-OI-8/27/2006
Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy
Warner, DF and Mizrahi, V
CLINICAL MICROBIOLOGY REVIEWS 2006. 19(3): 558-+, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239419600006
31. 58901 OI-LS-356; WOS-OI-8/27/2006
Antibacterial, antifungal and anticonvulsant evaluation of novel newly synthesized 1-[2-(1H-tetrazol-5-yl)eth l]-1H-benzo[d][1,2,3]triazoles
Rajasekaran, A, Murugesan, S, and AnandaRajagopal, K
ARCHIVES OF PHARMACAL RESEARCH 2006. 29(7): 535-540, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239411500001
32. 58902 OI-LS-356; WOS-OI-9/3/2006
In vitro selected Con1 subgenomic replicons resistant to 2 '-C-methyl-cytidine or to R1479 show lack of cross resistance
Le Pogam, S, Jiang, WR, Leveque, V, Rajyaguru, S, Ma, H, Kang, H, Jiang, S, Singer, M , Ali, S, Klumpp, K, Smith, D, Symons, J, Cammack, N, and Najera, I
VIROLOGY 2006. 351(2): 349-359, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239649500010
33. 58903 OI-LS-356; WOS-OI-9/3/2006
Synthesis and antimycobacterial activity of new 2-hydroxy-N-(3-oxo-1-thia-4-azaspiro[4.4]non-4- l)/(3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2,2-d phenylacetamide derivatives
Guzel, O, Ithan, E, and Salman, A
MONATSHEFTE FUR CHEMIE 2006. 137(6): 795-801, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239791700011
34. 58904 OI-LS-356; WOS-OI-9/3/2006
Utilization of ribozymes as antiviral agents
Benitez-Hess, ML and Alvarez-Salas, LM
LETTERS IN DRUG DESIGN & DISCOVERY 2006. 3(6): 390-404, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239768400005
35. 58905 OI-LS-356; WOS-OI-9/3/2006
Antitubercular properties of substituted hydroxycyclohexadienones
Shah, M, Wells, G, Bradshaw, TD, Laughton, CA, Stevens, MFG, and Westwell, AD
LETTERS IN DRUG DESIGN & DISCOVERY 2006. 3(6): 419-423, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239768400008
36. 58906 OI-LS-356; WOS-OI-9/3/2006
Synthesis and in vitro anti-tubercular activity of a series of N '-(disubstitutedbenzoyl)isoniazid derivatives
Junior, IN, Lourenco, MCS, de, Mirandal GDB, Vasconcelos, TRA, Pais, KC, Junior, JDD, Wardell, SMSV, Wardell, JL, and de, Souza MVN
LETTERS IN DRUG DESIGN & DISCOVERY 2006. 3(6): 424-428, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239768400009
37. 58907 OI-LS-356; WOS-OI-9/3/2006
Evaluation of a modified antimycobacterial susceptibility test using Middlebrook 7H10 agar containing 2,3-diphenyl-5-thienyl-(2)tetrazolium chloride
Lee, S, Kong, DH, Yun, SH, Lee, KR, Lee, KP, Franzblau, SG, Lee, EY, and Chang, CL
JOURNAL OF MICROBIOLOGICAL METHODS 2006. 66(3): 548-551, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239671600018
38. 58908 OI-LS-356; WOS-OI-9/3/2006
Antifungal activity of some coumarins obtained from species of Pterocaulon (Asteraceae)
Stein, AC, Alvarez, S, Avancini, C, Zacchino, S, and von, Poser G
JOURNAL OF ETHNOPHARMACOLOGY 2006. 107(1): 95-98, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239676000016
39. 58909 OI-LS-356; WOS-OI-9/3/2006
Synthesis and antifungal activity of new thienyl and aryl conazoles
Chevreuil, F, Landreau, A, Seraphin, D, Larcher, G, Bouchara, JP, and Richomme, P
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2006. 21(3): 293-303, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239088900007
40. 58910 OI-LS-356; WOS-OI-9/3/2006
Identification of an antimicrobial entity from the cyanobacterium Fischerella sp isolated from bark of Azadirachta indica (Neem) tree
Asthana, RK, Srivastava, A, Singh, AP, Deepali, Singh, SP, Nath, G, Srivastava, R, and Srivastava, BS
JOURNAL OF APPLIED PHYCOLOGY 2006. 18(1): 33-39, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239590800005
41. 58911 OI-LS-356; WOS-OI-9/3/2006
Antimicrobial activity of coupled hydroxyanthracenones isolated from plants of the genus Karwinskia
Salazar, R, Rivas, V, Gonzalez, G, and Waksman, N
FITOTERAPIA 2006. 77(5): 398-400, 3
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239668200013
42. 58912 OI-LS-356; WOS-OI-9/3/2006
Toxoplasma gondii scavenges host-derived lipoic acid despite its de novo synthesis in the apicoplast
Crawford, MJ, Thomsen-Zieger, N, Ray, M, Schachtner, J, Roos, DS, and Seeber, F
EMBO JOURNAL 2006. 25(13): 3214-3222, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239625800024
43. 58913 OI-LS-356; WOS-OI-9/3/2006
Anti-RNA virus activity of polyoxometalates
Shigeta, S, Mori, S, Yamase, T, Yamamoto, N, and Yamamoto, N
BIOMEDICINE & PHARMACOTHERAPY 2006. 60(5): 211-219, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239697600001
44. 58914 OI-LS-356; WOS-OI-9/3/2006
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobactetium tuberculosis
Hazbon, MH, Brimacombe, M, del, Valle MB, Cavatore, M, Guerrero, MI, Varma-Basil, M, Billman-Jacobe, H, Lavender, C, Fyfe, J, Garcia-Garcia, L, Leon, CI, Bose, M, Chaves, F, Murray, M, Eisenach, KD, Sifuentes-Osornio, J, Cave, MD, de, Leon AP, and Alland, D
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2006. 50(8): 2640-2649, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239640400007
45. 58915 OI-LS-356; WOS-OI-9/3/2006
Differential gene expression in response to exposure to antimycobacterial agents and other stress conditions among seven Mycobacterium tuberculosis whiB-like genes
Geiman, DE, Raghunand, TR, Agarwal, N, and Bishai, WR
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2006. 50(8): 2836-2841, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239640400035
46. 58916 OI-LS-356; WOS-OI-9/3/2006
Genetic basis for natural and acquired resistance to the diarylquinoline R207910 in mycobacteria
Petrella, S, Cambau, E, Chauffour, A, Andries, K, Jarlier, V, and Sougakoff, W
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2006. 50(8): 2853-2856, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239640400039
47. 58917 OI-LS-356; WOS-OI-9/3/2006
Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants
Huitric, E, Werngren, J, Jureen, P, and Hoffner, S
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2006. 50(8): 2860-2862, 3
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239640400041